Oncofocus Solutions Private Limited logo

Oncofocus Solutions Private Limited

Oncology research and consulting firm providing primary market research and competitive intelligence.
2014 | Bangaluru, Karnataka (India) | Active

Last Updated:

November 16, 2024
HomeCompanyOncofocus Solutions Private Limited

Who are the key members and board of directors at Oncofocus Solutions?

Board Members(2)

NameDesignationAppointment DateStatus
Ashish Shukla In Director 01-Jan-2014Current
Vimla Shukla In Director 01-Jan-2014Current

Financial Performance of Oncofocus Solutions.

Oncofocus Solutions Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.93% increase. The company also saw a substantial improvement in profitability, with a 349.97% increase in profit. The company's net worth Soared by an impressive increase of 128.93%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
28.93%
Revenue from Operations
29.56%
Total Assets
137.42%
Profit or Loss
349.97%
Net Worth
128.93%
EBITDA
189.58%

Charges (Loans)

Charges

There are no open charges registered against the company as per our records.

How Many Employees Work at Oncofocus Solutions?

Oncofocus Solutions has a workforce of 19 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Oncofocus Solutions

Recent activity within the organization

  • Annual General Meeting

    Oncofocus Solutions Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Oncofocus Solutions Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.

    31 Mar 2023

  • Director Appointment

    Ashish Shukla was appointed as a Director was appointed as a Director on 01 Jan 2014 & has been associated with this company since 11 years 15 days .

    01 Jan 2014

  • Director Appointment

    Vimla Shukla was appointed as a Director was appointed as a Director on 01 Jan 2014 & has been associated with this company since 11 years 15 days .

    01 Jan 2014

  • Company Incorporation

    Oncofocus Solutions Private Limited was registered on 01 Jan 2014 with Roc Bangalore & aged 11 years 15 days as per MCA records.

    01 Jan 2014

Frequently asked questions

  • Oncofocus Solutions Private Limited was incorporated on 01 Jan 2014.

  • The authorized share capital of Oncofocus Solutions Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Oncofocus Solutions Private Limited.

    • Ashish Shukla
    • Vimla Shukla
  • As per Ministry of Corporate Affairs (Mca), the registered address of Oncofocus Solutions Private Limited is Gopala Krishna Complex 45/3 Residency Road Mg Road Bengaluru, India, Bangalore, Karnataka, 560025.

  • The corporate identification number (CIN) of Oncofocus Solutions Private Limited is U74200KA2014PTC072812 and the company number is 072812 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Oncofocus Solutions Private Limited is https://www.oncofocus.com

  • According to the financial reports for the fiscal year 2023, the revenue trend for Oncofocus Solutions Private Limited has risen by 28.93%.

  • As Per 2023 financial reports, 19 employees are currently employed by Oncofocus Solutions Private Limited.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Oncofocus Solutions Private Limited has experienced an upsurge of 128.93%.

  • The most recent Balance Sheet for Oncofocus Solutions Private Limited was filed with the ROC on 31 Mar 2023.

Similar Companies Based on Oncology Clinics & Cancer Treatment